feed,title,long_url,short_url
Benzinga,InflaRx to Present at Upcoming Annual J.P. Morgan Healthcare Conference,https://www.benzinga.com/pressreleases/21/01/g19055860/inflarx-to-present-at-upcoming-annual-j-p-morgan-healthcare-conference,https://j.mp/3s1ZvaO
Benzinga,Athira Pharma to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.benzinga.com/pressreleases/21/01/g19055858/athira-pharma-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference,https://j.mp/396UXYh
Benzinga,Red Light Holland Announces $5 Million Bought Deal Equity Financing,https://www.benzinga.com/pressreleases/21/01/g19055857/red-light-holland-announces-5-million-bought-deal-equity-financing,https://j.mp/2JQjZSG
Benzinga,Kura Oncology to Participate in H.C. Wainwright BioConnect 2021 Conference,https://www.benzinga.com/pressreleases/21/01/g19055856/kura-oncology-to-participate-in-h-c-wainwright-bioconnect-2021-conference,https://j.mp/39drBqW
Benzinga,nCino to Present at the 23rd Annual Needham Virtual Growth Conference,https://www.benzinga.com/pressreleases/21/01/g19055851/ncino-to-present-at-the-23rd-annual-needham-virtual-growth-conference,https://j.mp/3nltmHN
Benzinga,LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies for Rare and Non-Rare Monogenic Diseases,https://www.benzinga.com/pressreleases/21/01/g19055850/lexeo-therapeutics-launches-with-85-million-series-a-financing-to-develop-gene-therapies-for-rare-,https://j.mp/3bfVZ6X
